Related Experiment Video
Updated: Jul 20, 2025

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
Reg3γ: current understanding and future therapeutic opportunities in metabolic disease
Jae Hoon Shin1, Nadejda Bozadjieva-Kramer2, Randy J Seeley3
1Department of Surgery, University of Michigan, Ann Arbor, MI, USA.
Abstract:
Regenerating family member gamma, Reg3γ (the mouse homolog of human REG3A), belonging to the antimicrobial peptides (AMPs), functions as a part of the host immune system to maintain spatial segregation between the gut bacteria and the host in the intestine via bactericidal activity. There is emerging evidence that gut manipulations such as bariatric surgery, dietary supplementation or drug treatment to produce metabolic benefits alter the gut microbiome. In addition to changes in a wide range of gut hormones, these gut manipulations also induce the expression of Reg3γ in the intestine. Studies over the past decades have revealed that Reg3γ not only plays a role in the gut lumen but can also contribute to host physiology through interaction with the gut microbiota. Herein, we discuss the current knowledge regarding the biology of Reg3γ, its role in various metabolic functions, and new opportunities for therapeutic strategies to treat metabolic disorders.
More Related Videos
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
09:16Real-Time Analysis of Bioenergetics in Primary Human Retinal Pigment Epithelial Cells Using High-Resolution Respirometry
Published on: February 3, 2023
Related Concept Videos
Regulation of Metabolism
Microorganisms in Medicine and Therapeutics
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Regulation of the Unfolded Protein Response
Regulated Protein Degradation
Global Regulatory Systems